Trump Administration Reportedly Dissenting from Medicare Coverage Expansion for Weight Management Drugs
Sources indicate that the team associated with former President Donald Trump is expressing opposition to a proposition initiated during the Biden administration. This plan aimed to broaden Medicare’s scope to encompass medications intended for weight reduction, specifically referencing pharmaceutical options like Wegovy and Zepbound.
Source
